UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$234M |
| 2 |
Home Depot
HD
|
+$214M |
| 3 |
Intercontinental Exchange
ICE
|
+$206M |
| 4 |
TJX Companies
TJX
|
+$129M |
| 5 |
BorgWarner
BWA
|
+$122M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$227M |
| 2 |
DFS
Discover Financial Services
DFS
|
+$212M |
| 3 |
Mohawk Industries
MHK
|
+$137M |
| 4 |
Liberty Global Class A
LBTYA
|
+$114M |
| 5 |
Freeport-McMoran
FCX
|
+$112M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 14.05% |
| 2 | Technology | 13.96% |
| 3 | Financials | 13.95% |
| 4 | Industrials | 9.13% |
| 5 | Energy | 8.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
DSCI
1026
DELISTED
Derma Sciences, Inc. Common Stock (DE)
DSCI
| $4.33M | ﹤0.01% |
374,162
+114,504
| +44% | +$1.18M |
|
1027
SM Energy
SM
$7.44B
| $4.32M | ﹤0.01% |
51,407
+13,830
| +37% | +$1.06M |
|
|
TRNX
1028
DELISTED
TORNIER N V SHARES (NLD)
TRNX
| $4.3M | ﹤0.01% |
183,930
+136,530
| +288% | +$2.84M |
|
|
SRGA
1029
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
| $4.3M | ﹤0.01% |
32,918
-15,636
| -32% | -$1.99M |
|
1030
Healthcare Realty
HR
$7.02B
| $4.29M | ﹤0.01% |
178,368
+24,850
| +16% | +$592K |
|
1031
NVR
NVR
$16.8B
| $4.29M | ﹤0.01% |
3,729
-8,700
| -70% | -$9.71M |
|
|
RCPT
1032
DELISTED
RECEPTOS INC COM STK (DE)
RCPT
| $4.28M | ﹤0.01% |
100,433
-6,395
| -6% | -$221K |
|
1033
Myriad Genetics
MYGN
$303M
| $4.28M | ﹤0.01% |
109,942
-589,821
| -84% | -$21.9M |
|
1034
Hope Bancorp
HOPE
$1.83B
| $4.27M | ﹤0.01% |
267,588
+918
| +0.3% | +$14.5K |
|
1035
Trinity Industries
TRN
$2.55B
| $4.26M | ﹤0.01% |
135,366
+1,111
| +0.8% | +$31.5K |
|
|
GRA
1036
DELISTED
W.R. Grace & Co.
GRA
| $4.26M | ﹤0.01% |
45,044
+400
| +0.9% | +$37.7K |
|
1037
H.B. Fuller
FUL
$3.17B
| $4.22M | ﹤0.01% |
87,760
+110
| +0.1% | +$5.26K |
|
|
DRC
1038
DELISTED
DRESSER-RAND GROUP INC
DRC
| $4.22M | ﹤0.01% |
66,228
-178
| -0.3% | -$10.9K |
|
1039
Banco de Chile
BCH
$20.9B
| $4.16M | ﹤0.01% |
174,857
| – | – |
|
|
IRE
1040
DELISTED
GOVERNOR-BK OF IRELND ADS NEW
IRE
| $4.14M | ﹤0.01% |
298,179
+51,084
| +21% | +$828K |
|
1041
Watsco Inc
WSO
$13.8B
| $4.14M | ﹤0.01% |
40,311
+4,917
| +14% | +$498K |
|
|
BRLI
1042
DELISTED
BIO-REFERENCE LABS INC-NEW-
BRLI
| $4.14M | ﹤0.01% |
136,855
-4,144
| -3% | -$114K |
|
|
HUB.B
1043
DELISTED
HUBBELL INC CL-B
HUB.B
| $4.11M | ﹤0.01% |
33,363
+1,600
| +5% | +$189K |
|
|
XLRN
1044
DELISTED
Acceleron Pharma
XLRN
| $4.1M | ﹤0.01% |
120,800
+56,200
| +87% | +$1.88M |
|
1045
Evercore
EVR
$12.4B
| $4.1M | ﹤0.01% |
71,120
+10,479
| +17% | +$575K |
|
1046
AngloGold Ashanti
AU
$41.2B
| $4.08M | ﹤0.01% |
236,967
-11,153
| -4% | -$190K |
|
|
CLC
1047
DELISTED
Clarcor
CLC
| $4.05M | ﹤0.01% |
65,557
+65
| +0.1% | +$3.76K |
|
|
SPIL
1048
DELISTED
Siliconware Precision Industries Co Ltd
SPIL
| $4.05M | ﹤0.01% |
493,800
+71,800
| +17% | +$540K |
|
|
PL
1049
DELISTED
PROTECTIVE LIFE CORP
PL
| $4.03M | ﹤0.01% |
58,146
+400
| +0.7% | +$22.8K |
|
1050
Enovis
ENOV
$1.78B
| $3.98M | ﹤0.01% |
31,021
+2,208
| +8% | +$276K |
|
Similar funds
UBS AM's Q2 2014 Portfolio in Review
As of Q2 2014, UBS AM held 2,651 positions worth $99B, up 5.7% from $93.7B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
UBS AM's Q2 2014 filing shows 81 new, 1,135 increased, 556 reduced and 97 closed positions. Its largest new stake was Sabre: 3,529,400 shares worth $70.8M. The largest sale was Allergan Inc, an estimated $227M.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, down from 14% a quarter earlier, followed by Technology and Financials.
- UBS AM's largest Q2 2014 buy was Sabre: 3,529,400 shares worth $70.8M.
- UBS AM added most to Thermo Fisher Scientific in Q2 2014, an estimated $234M increase.
- UBS AM's biggest Q2 2014 reduction was Allergan Inc, cutting an estimated $227M.
- UBS AM fully exited Freeport-McMoran in Q2 2014, selling an estimated $112M.
- UBS AM's ten largest holdings make up 14% of its $99B portfolio in Q2 2014.
- UBS AM opened 81 new positions and closed 97 in Q2 2014.
- UBS AM's portfolio value rose 5.7% quarter-over-quarter to $99B.
Based on UBS AM's 13F filing for Q2 2014, filed 13 Aug 2014.